250 related articles for article (PubMed ID: 10390602)
21. Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice.
Yung S; Zhang Q; Chau MK; Chan TM
Autoimmunity; 2015; 48(7):471-87. PubMed ID: 26099989
[TBL] [Abstract][Full Text] [Related]
22. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
23. From mice to man: the preclinical history of mycophenolate mofetil.
Sollinger HW
Clin Transplant; 1996 Feb; 10(1 Pt 2):85-92. PubMed ID: 8680054
[TBL] [Abstract][Full Text] [Related]
24. Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells.
Morath C; Zeier M
Int J Clin Pharmacol Ther; 2003 Oct; 41(10):465-9. PubMed ID: 14703952
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of action of mycophenolate mofetil.
Ransom JT
Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
[TBL] [Abstract][Full Text] [Related]
26. Inosine monophosphate dehydrogenase activity in renal allograft recipients during mycophenolate treatment.
Vethe NT; Mandla R; Line PD; Midtvedt K; Hartmann A; Bergan S
Scand J Clin Lab Invest; 2006; 66(1):31-44. PubMed ID: 16464785
[TBL] [Abstract][Full Text] [Related]
27. Antifibrotic actions of mycophenolic acid.
Morath C; Schwenger V; Beimler J; Mehrabi A; Schmidt J; Zeier M; Muranyi W
Clin Transplant; 2006; 20 Suppl 17():25-9. PubMed ID: 17100698
[TBL] [Abstract][Full Text] [Related]
28. Mizoribine in the treatment of rheumatoid arthritis and juvenile idiopathic arthritis.
Takei S
Pediatr Int; 2002 Apr; 44(2):205-9. PubMed ID: 11896888
[TBL] [Abstract][Full Text] [Related]
29. Mizoribine versus mycophenolate mofetil in combination therapy with tacrolimus for de novo kidney transplantation: evaluation of efficacy and safety.
Ju MK; Huh KH; Park KT; Kim SJ; Cho BH; Kim CD; So BJ; Kang CM; Lee S; Joo DJ; Kim YS
Transplant Proc; 2013 May; 45(4):1481-6. PubMed ID: 23726602
[TBL] [Abstract][Full Text] [Related]
30. Mycophenolate mofetil: a dermatologic perspective.
Mydlarski PR
Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
[TBL] [Abstract][Full Text] [Related]
31. Mycophenolate mofetil.
Sollinger HW
Kidney Int Suppl; 1995 Dec; 52():S14-7. PubMed ID: 8587275
[TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil in pediatric renal transplantation.
Weber LT; Höcker B; Mehls O; Tönshoff B
Minerva Urol Nefrol; 2003 Mar; 55(1):91-9. PubMed ID: 12773970
[TBL] [Abstract][Full Text] [Related]
33. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
Staatz CE; Tett SE
Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
[TBL] [Abstract][Full Text] [Related]
34. Acute Inflammatory Syndrome Paradoxically Induced by De Novo Purine Inhibitors Synthesis Before Renal Transplantation: A Case Report and Review of the Literature.
Maruyama Y; Sadahira T; Mitsui Y; Wada K; Tanimoto R; Nishimura S; Kobayashi Y; Watanabe T; Nasu Y; Araki M
Transplant Proc; 2018 Apr; 50(3):895-897. PubMed ID: 29571743
[TBL] [Abstract][Full Text] [Related]
35. Mizoribine selectively attenuates monocyte chemoattractant protein-1 production in cultured human glomerular mesangial cell: a possible benefit of its use in the treatment of lupus nephritis.
Aizawa T; Imaizumi T; Tsuruga K; Watanabe S; Chiba Y; Matsumiya T; Yoshida H; Tanaka H
Nephrology (Carlton); 2014 Jan; 19(1):47-52. PubMed ID: 24134561
[TBL] [Abstract][Full Text] [Related]
36. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
Klupp J; van Gelder T; Dambrin C; Regieli JJ; Boeke K; Billingham ME; Morris RE
J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644
[TBL] [Abstract][Full Text] [Related]
37. Effect of mizoribine on collagen-induced arthritis in mice.
Kamada H; Nakagami K
Jpn J Pharmacol; 1996 Feb; 70(2):169-75. PubMed ID: 8866754
[TBL] [Abstract][Full Text] [Related]
38. Effects of mizoribine on MHC-restricted exogenous antigen presentation in dendritic cells.
Song Y; Han S; Kim H; Kim K; Kwon J; Lee SJ; Ha NJ; Lee YH; Lee CK; Kim K
Arch Pharm Res; 2006 Dec; 29(12):1147-53. PubMed ID: 17225465
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil.
Maksimovic-Ivanic D; Trajkovic V; Miljkovic DJ; Mostarica Stojkovic M; Stosic-Grujicic S
Clin Exp Immunol; 2002 Aug; 129(2):214-23. PubMed ID: 12165076
[TBL] [Abstract][Full Text] [Related]
40. Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ozono S; Kagawa Y; Kawakami J
Clin Chim Acta; 2009 Nov; 409(1-2):56-61. PubMed ID: 19723513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
